VCEL Vericel Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: VCEL

Price (delayed)

$35.62

Market cap

$1.82B

P/E Ratio

82.84

Dividend/share

N/A

EPS

$0.43

Enterprise value

$1.8B

?
Relative Growth: Rel. Growth: 93
Relative Strength: Rel. Strength: 39
Relative Valuation: Rel. Valuation: 47
Relative Profitability: Rel. Profitability: 74

Vericel is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI® (autologous cultured ...

Highlights
The stock's P/E is 47% less than its last 4 quarters average of 152.2
The EPS has grown by 30% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://vcel.com
Peers: RPRX NEOG

Key stats

What are the main financial stats of VCEL

VCEL stock price

How has the Vericel stock price performed over time
Intraday
2.53%
1 week
4.03%
1 month
-2.38%
1 year
-17.49%
YTD
-1.08%
QTD
10.72%

Financial performance

How have Vericel's revenue and profit performed over time
Revenue
$292.09M
Gross profit
$218.59M
Operating income
$15.77M
Net income
$21.46M
Gross margin
74.8%
Net margin
7.3%
Vericel's operating income has increased by 43% QoQ
Vericel's operating margin has increased by 35% from the previous quarter
The net income is up by 30% QoQ
The gross profit has grown by 26% YoY and by 6% from the previous quarter

Price vs fundamentals

How does VCEL's price correlate with its fundamentals

Growth

What is Vericel's growth rate over time

Valuation

What is Vericel stock price valuation
VCEL P/E details
P/E
82.84
P/B
5.08
P/S
6.19
EV/EBIT
78.59
EV/EBITDA
44.64
EV/Sales
6.18
The stock's P/E is 47% less than its last 4 quarters average of 152.2
The EPS has grown by 30% from the previous quarter
VCEL's price to book (P/B) is 42% lower than its 5-year quarterly average of 8.5 and 8% lower than its last 4 quarters average of 5.4
The equity rose by 21% year-on-year
VCEL's price to sales (P/S) is 36% lower than its 5-year quarterly average of 9.5 and 10% lower than its last 4 quarters average of 6.7
The revenue has grown by 22% YoY and by 6% from the previous quarter

Efficiency

How efficient is Vericel business performance
The ROIC is up by 25% since the previous quarter
Vericel's return on assets has increased by 24% QoQ
VCEL's ROE is up by 23% from the previous quarter
The ROS has grown by 22% from the previous quarter

Dividends

What is VCEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VCEL.

Financial health

How did Vericel financials performed over time
The total assets has increased by 14% YoY
The quick ratio has increased by 6% year-on-year and by 2.2% since the previous quarter
The debt is 73% lower than the equity
The equity rose by 21% year-on-year
Vericel's debt to equity has decreased by 18% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.